Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Pfizer to Take Stake in $2.2 Billion Shanghai Pharma IPO

publication date: May 3, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Pfizer will purchase a $50 million stake in Shanghai Pharmaceutical’s upcoming Hong Kong IPO. Pfizer was one of four companies announced to be major investors in the offering, which is now expected to raise as much as $2.2 billion. That’s $1 billion more than anticipated when the transaction was announced in September of 2010. More details....

Stock Symbols: (NYSE: PFE) (SHA: 601607)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...